StockWatch
·

Concord Drugs Ltd

BSE: 538965

Shareholding Trends

Ownership split

PromoterPublicOthers
0%21%41%62%Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Institutional detail

FII / FPIDII
0%0%1%1%Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Q1 FY27

Corporate Events

Board MeetingCONCORD
2026
12Nov

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingCONCORD
2026
30Sep

Board Meeting

The Annual General Meeting (AGM) of the Company is scheduled…

BSE Filing ↗
Board MeetingCONCORD
2026
7Sep

Board Meeting

The Board of Directors met to approve the Notice and Annual …

BSE Filing ↗
Board MeetingCONCORD
2026
10Aug

Board Meeting

The meeting of the Board of Directors of Concord Drugs Limit…

BSE Filing ↗
Board MeetingCONCORD
2026
27May

Board Meeting

The board meeting is scheduled to consider and approve the a…

BSE Filing ↗
Board MeetingCONCORD
2025
3Jul

Board Meeting

Increase in Authorised Share Capital and Alteration of Memor…

BSE Filing ↗
Board MeetingCONCORD
2025
19Jun

Board Meeting

Temporarily put on hold the company's proposal to raise fund…

BSE Filing ↗
Board MeetingCONCORD
2025
4Mar

Board Meeting

Proposal to raise funds through a preferential issue of shar…

BSE Filing ↗
Board MeetingCONCORD
2024
6Sep

Board Meeting

Raising of funds for expansion of business and to explore ne…

BSE Filing ↗
Board MeetingCONCORD
2024
25May

Board Meeting

Audited Financial results (standalone & Consolidated) for th…

BSE Filing ↗